Arthroplasty

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Medacta
MedactaSwitzerland - Castel San Pietro
2 programs
AMIStem-HN/A1 trial
Dynamic videofluoroscopic analysisN/A1 trial
Active Trials
NCT02829866CompletedEst. Oct 2021
NCT02828293UnknownEst. Jun 2019
Plus Therapeutics
1 program
Stability Plus - Outcomes From Extended Continuum of CareN/A1 trial
Active Trials
NCT00756483UnknownEst. Oct 2009

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MedactaDynamic videofluoroscopic analysis
MedactaAMIStem-H
Plus TherapeuticsStability Plus - Outcomes From Extended Continuum of Care

Clinical Trials (3)

NCT02828293MedactaDynamic videofluoroscopic analysis

Understanding GMK Sphere Implant Tibiofemoral Kinematics by Means of Dynamic Videofluoroscopy

Start: Sep 2014Est. completion: Jun 2019
N/AUnknown
NCT02829866MedactaAMIStem-H

AMIStem-H Radiographic Analysis

Start: Sep 2010Est. completion: Oct 2021
N/ACompleted
NCT00756483Plus TherapeuticsStability Plus - Outcomes From Extended Continuum of Care

Stability Plus - Outcomes From Extended Continuum of Care

Start: Oct 2008Est. completion: Oct 2009
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space